Kolexia
De Fraipont Florence Pharmacien
De Fraipont Florence
Pharmacien
Hôpital Nord Grenoble
La Tronche, France
74 Activités
24 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Mélanome Adénocarcinome Carcinomes Adénocarcinome pulmonaire Accident vasculaire cérébral Métastase tumorale

Collaborateurs

Voir plus
Moro-Sibilot Denis
Moro-Sibilot Denis
Hôpital Nord Grenoble, La Tronche, France
Blons Helene
Blons Helene
Hôpital Européen Georges Pompidou, Paris, France
Cadranel Jacques
Cadranel Jacques
Hôpital Tenon, Paris, France
Beau-Faller Michèle
Beau-Faller Michèle
Hôpital Hautepierre, Strasbourg, France

Industries

Voir plus
AstraZeneca
8 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe.
ESMO open   14 septembre 2023
The melanoma tumor glyco-code impacts human dendritic cells' functionality and dictates clinical outcomes.
Frontiers in immunology   20 février 2023
Unique CLR expression patterns on circulating and tumor-infiltrating DC subsets correlated with clinical outcome in melanoma patients.
Frontiers in immunology   24 octobre 2022
Altered splicing of ATG16-L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non-small cell lung cancer.
Molecular oncology   30 août 2022
Diversification of circulating and tumor-infiltrating plasmacytoid DCs towards the P3 (CD80 PDL1 )-pDC subset negatively correlated with clinical outcomes in melanoma patients.
Clinical & translational immunology   03 mai 2022
Séquence thérapeutique en vraie vie des patients présentant un carcinome bronchique non à petites cellules métastatiques avec mutation activatrice de l’EGFR
26e CONGRÈS DE PNEUMOLOGIE DE LANGUE FRANÇAISE   01 janvier 2022
Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes.
Clinical & translational immunology   09 novembre 2021
BDCA1 cDC2s, BDCA2 pDCs and BDCA3 cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients.
Clinical & translational immunology   24 novembre 2020
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project.
Lung cancer (Amsterdam, Netherlands)   13 novembre 2020